Search

Showing "11155" results for ""

US guidance says that pregnant women should not take nelfinavir

Cognitive impairment common in people with HIV despite antiretroviral therapy

Onset of HIV dementia predicted by falling platelet count

T-20 increases tipranavir levels but does not increase risk of liver side-effects

Virologically failing NNRTI regimens have higher resistance risk than failing boosted-PIs

Condoms, not serosorting explain stable HIV incidence in 'lower risk' Amsterdan gay men

CD4 cell loss not enough to cause AIDS in some monkeys

Breastfeeding transmission less likely if breast milk high in omega-6 fats

European researchers develop method of calculating short-term risk of HIV disease progression

Mantoux test good predictor of HIV-positive women's response to HPV

ICAAC: High mortality rate from symptomatic lactic acidosis in Thailand

ICAAC: Hardening of the arteries found in one in five patients in Swiss HIV cohort

ICAAC: Moxifloxacin could cut TB treatment time to four months

ICAAC: In NNRTI-based regimens, stepwise discontinuation minimises risk of antiretroviral resistance

ICAAC: Boosted darunavir non-inferior to boosted lopinavir after 48 weeks in treatment-naïve

ICAAC: Vicriviroc safe, effective after 2 years, phase III studies start soon

ICAAC: Raltegravir shows sustained effect in highly treatment-experienced patients

ICAAC: Best response to elvitegravir seen when used with T-20 and other active agents

Receive the latest HIV research and conference news

Showing "11155" results for ""

US guidance says that pregnant women should not take nelfinavir

Cognitive impairment common in people with HIV despite antiretroviral therapy

Onset of HIV dementia predicted by falling platelet count

T-20 increases tipranavir levels but does not increase risk of liver side-effects

Virologically failing NNRTI regimens have higher resistance risk than failing boosted-PIs

Condoms, not serosorting explain stable HIV incidence in 'lower risk' Amsterdan gay men

CD4 cell loss not enough to cause AIDS in some monkeys

Breastfeeding transmission less likely if breast milk high in omega-6 fats

European researchers develop method of calculating short-term risk of HIV disease progression

Mantoux test good predictor of HIV-positive women's response to HPV

ICAAC: High mortality rate from symptomatic lactic acidosis in Thailand

ICAAC: Hardening of the arteries found in one in five patients in Swiss HIV cohort

ICAAC: Moxifloxacin could cut TB treatment time to four months

ICAAC: In NNRTI-based regimens, stepwise discontinuation minimises risk of antiretroviral resistance

ICAAC: Boosted darunavir non-inferior to boosted lopinavir after 48 weeks in treatment-naïve

ICAAC: Vicriviroc safe, effective after 2 years, phase III studies start soon

ICAAC: Raltegravir shows sustained effect in highly treatment-experienced patients

ICAAC: Best response to elvitegravir seen when used with T-20 and other active agents

Receive the latest HIV research and conference news